期刊文献+

Anti-DR5 mAb诱导佐剂型关节炎大鼠滑膜细胞凋亡及机理初探

Induction of apoptosis by Anti-DR5 mAb in synovial cells of adjuvant arthritis rats and its possible mechanisms
下载PDF
导出
摘要 目的:探讨Anti-DR5 mAb诱导佐剂型关节炎(Adjuvant Arthritis,AA)大鼠滑膜细胞凋亡作用及其可能机理。方法:注射弗氏完全佐剂建立AA大鼠模型,分离并体外培养大鼠滑膜细胞。MTT检测、DNA倍体分析及流式细胞术分析Anti-DR5 mAb对大鼠滑膜细胞的凋亡作用,Western blot检测大鼠滑膜细胞Caspase-3、Bcl-2蛋白的表达,Caspase抑制剂实验分析Anti-DR5 mAb对大鼠滑膜细胞凋亡作用的机制。结果:MTT实验表明Anti-DR5 mAb能抑制大鼠滑膜细胞的增殖,流式细胞术分析这种作用模式为细胞凋亡。Anti-DR5 mAb处理后的大鼠滑膜细胞中Caspase-3蛋白水平上升,Bcl-2蛋白水平下调。Cas-pase抑制剂实验证明Anti-DR5 mAb诱导大鼠滑膜细胞的凋亡是通过Caspase途径实现的。结论:Anti-DR5 mAb诱导大鼠滑膜细胞的凋亡,这种作用与滑膜细胞表面Caspase-3、Bcl-2蛋白表达相关。 Objective:To study the effects of Anti-DR5 mAb on inducing synovial cells of adjuvant arthritis (AA) rats and its mechanisms.Methods: AA was induced by CFA in rats.The synovial cells of rats were separated and cultured in vitro system. The apoptosis induced by anti-DR5 mAb on synovial cells was measured by MTT analysis, DNA fragmentation and flow cytometry. Caspase-3 and Bcl-2 expression in synovial cells were detected by Western blot. The involvement of the apoptotic pathway was further proved by a caspase inhibition assay. Resulls:MTT result showed that Anti-DR5 mAb could inhibit synovial cells growth. And flow cytometry suggested that the cell death mode was apoptosis. The protein level of caspase-3 in synovial cells treated with anti-DR5 mAb was raised, while Bcl-2 level declined. When the caspase inhibitor was added to the synovial cells treated with anti-DR5 mAb, it was showed in a dose-dependence inhibition effect, indicating that anti- DR5 mAb inducing apoptosis might be through the caspase pathway. Conclusion: Anti-DR5 mAb could induce synovial cell apoptosis through caspase pathway. And this effect may be related to the protein level of Caspase-3 and Bcl-2.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2009年第11期969-972,共4页 Chinese Journal of Immunology
基金 福建省自然科学基金项目(C0710046)
关键词 Anti-DR5 MAB 佐剂型关节炎 滑膜细胞 细胞凋亡 Anti-DR5 mAb Adjuvant arthritis Synovial cells Cell apoptosis
  • 相关文献

参考文献15

  • 1周京国,郭晓兰,唐中,袁国华,魏锦,杨明辉,何兰,蒋红.可溶性尿激酶型纤溶酶原激活物受体在RA患者血浆和滑液的水平及其临床意义[J].中华风湿病学杂志,2006,10(12):713-716. 被引量:5
  • 2Martinez-Lorenzo M J, Anel A, Saez-Gutierrez B et al. Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL [ J ]. Clin Immunol, 2007;122(1):28-40.
  • 3Firestein G S. Evolving concepts of rheumatoid arthrltis[ J ]. Nature,2003 ; 423(6937) :356-361.
  • 4Tsokos G C,Tsokos M.The TRAIL to arthritis[J]. Clin Invest,2003; 112 (9) : 1315-1317.
  • 5Lamhamedi-Cherradi S E, Zheng S J, Maguschak K A et al. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL^-/- mice [ J ]. Nature Immunol, 2003 ; 4(3 ) : 255-260.
  • 6Song K, Chen Y, Goke R et ol. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression [ J ]. J Exp Med, 2000; 191 (7) : 1095-1104.
  • 7朱冉旭,林菊生.死亡受体DR5与肿瘤细胞凋亡[J].世界华人消化杂志,2004,12(8):1909-1912. 被引量:5
  • 8David Lawrence,Zahra Shahrokh,Scot Marsters et al. Differential hepatocyte toxicity of recombinant Apo2L/FRA/L versions[ J ]. Nature Medicine, 2001 ;7(4) :383-385.
  • 9Ichikawa K,Liu W M,Fleck Met al .TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis[ J]. J Immunol, 2003;171 (2) : 1061-1069.
  • 10李文珠,陶惠然,庄国洪,胡庆中,王生育,陈彩霞.抗死亡受体DR5抗体对大鼠佐剂型关节炎的作用机理探讨[J].中华微生物学和免疫学杂志,2007,27(7):651-655. 被引量:2

二级参考文献90

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部